Back to Research

Organization profile

Hilo (formerly Aktiia)

Hilo, formerly known as Aktiia, is a Neuchâtel-based health-tech leader that provides a clinically validated, cuffless blood pressure monitoring platform. The organization combines a medical-grade wearable band with a proprietary Machine Learning model to offer 24/7 continuous monitoring and cardiovascular insights for hypertension management and prevention.38

Neuchâtel, SwitzerlandFounded 2018

Overview

1. Executive Summary (Confidence: High)

The transition from Aktiia to Hilo in May 2025 marks a new era for the company, following a successful $42 million Series B funding round that brought total investment to over $100 million. Hilo has achieved what was previously considered the "holy grail" of vascular monitoring: FDA 510(k) clearance for the first-ever cuffless blood pressure monitor for over-the-counter (OTC) use in the United States. With 130,000 devices sold and a database of 12 billion data points, the company is moving from a hardware-centric model to a "Blood Pressure Intelligence Platform". The 2026 strategy focuses on a massive US market entry and the integration of holistic lifestyle markers like sleep and movement to offer users a "lifelong cardiovascular companion".

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.